Extending rivaroxaban treatment after distal DVT reduces further clot risk Dr. Kamal Kant Kohli28 Nov 2022 12:30 PM ISTGiving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of...
Medical Bulletin 25/November/2022 Dr. Nandita Mohan25 Nov 2022 4:45 PM ISTHere are the top health news for the day:Further clot risk reduced by extending anti-clotting treatment after distal DVTGiving the anti-clotting drug...
Further clot risk reduced by extending anti-clotting treatment after distal DVT Dr. Nandita Mohan25 Nov 2022 9:00 AM ISTGiving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of...
Stroke, systemic embolism risk halved in AF patients with VHD who took apixaban versus Rivaroxaban Dr. Kamal Kant Kohli20 Oct 2022 11:45 AM ISTAccording to researchers at the Perelman School of Medicine at the University of Pennsylvania patients of Atrial fibrillation with VHD receiving...
Rivaroxaban ranks top for VTE prevention among immobilized patients following trauma Aditi3 Oct 2022 10:45 AM ISTFrance: A research article published in PLOS Medicine confirmed the efficacy of anticoagulants in preventing Venous Thromboembolism (VTE) in lower...
Rivaroxaban-balances bleeding risk in chronic coronary syndrome Dr. Nandita Mohan6 Sept 2022 10:00 AM ISTGlobally, the prevalence of chronic coronary syndrome (CCS) increases with age. In India, there is a rapidly growing burden of coronary artery disease...
In Rheumatic heart disease AF, rivaroxaban use raises death, stroke risk: INVICTUS Dr. Kamal Kant Kohli30 Aug 2022 8:00 PM ISTRheumatic heart disease is a chronic condition resulting from heart valve damage caused by rheumatic fever. One in five patients with...
Rivaroxaban Balances Bleeding Risk in Patients with Chronic Coronary Syndrome - JAPI Report Dr. Nandita Mohan13 Aug 2022 10:00 AM IST Rivaroxaban has a low risk of drug interactions, and it does not require regular monitoring for coagulation if given at fixed doses; owing to...
Top Medical Bulletin 30/June/2022 Isra Zaman30 Jun 2022 6:00 PM ISTHere are the top medical stories for today:Pollution exposure associated with multimorbidity riskExposure to the air pollution known as fine...
Rivaroxaban monotherapy reduces subsequent events risk in patients with AF and stable CAD: JAMA Dr. Hiral patel18 Jun 2022 11:30 AM ISTJapan: A post hoc secondary analysis of the AFIRE randomized clinical trial results published in JAMA Cardiology showed that rivaroxaban monotherapy...
Rivaroxaban effective in treating of Noncirrhotic Splanchnic Vein Thrombosis Medical Dialogues Editorial Team3 May 2022 9:30 AM ISTRivaroxaban has proven to be a suitable alternative to traditional anticoagulation in the treatment of non-cirrhotic splanchnic vein thrombosis (SVT),...
Low-dose rivaroxaban could prevent LVT formation in anterior STEMI patients after PCI: JACC Medha Baranwal11 April 2022 9:00 AM ISTChina: Results from a recent study support the short-duration addition of low-dose rivaroxaban to DAPT for preventing left ventricular thrombus (LVT)...
